{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:27:29Z","timestamp":1787837249347,"version":"build-2784847793"},"reference-count":93,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180505","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T17:54:25Z","timestamp":1501696465000},"page":"e0180505","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity"],"prefix":"10.1371","volume":"12","author":[{"given":"Sapna","family":"Pahil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-6138","authenticated-orcid":true,"given":"Neelam","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hifzur Rahman","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. P. S.","family":"Raghava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"ref1","first-page":"133","article-title":"Shigellosis","volume":"43","author":"SK Niyogi","year":"2005","journal-title":"J Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1371\/journal.pmed.0030353","article-title":"A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology","volume":"3","author":"L von Seidlein","year":"2006","journal-title":"PLoS Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"KL Kotloff","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JCM.02713-12","article-title":"Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries","volume":"51","author":"B Lindsay","journal-title":"J Clin Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"J Liu","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra1207777","article-title":"Enteropathogens and chronic illness in returning travelers","volume":"368","author":"AG Ross","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4269\/ajtmh.2006.74.891","article-title":"Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review","volume":"74","author":"MS Riddle","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/132.1.15","article-title":"An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal","volume":"132","author":"MM Rahaman","year":"1975","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0140-6736(84)91948-2","article-title":"Epidemic bacillary dysentery in West Bengal, India, 1984","volume":"1","author":"SC Pal","year":"1984","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1473-3099(04)01143-0","article-title":"Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh","volume":"4","author":"A Naheed","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"ref11","first-page":"195","article-title":"Clinical presentation of shigellosis during the 1984 epidemic of bacillary dysentery in West Bengal","volume":"35","author":"P Dutta","year":"1987","journal-title":"J Assoc Physicians India"},{"key":"ref12","first-page":"161","article-title":"Epidemic Shiga bacillus dysentery in Port Blair, Andaman and Nicobar Islands, India","volume":"4","author":"D Sen","year":"1986","journal-title":"J Diarrhoeal Dis Res"},{"key":"ref13","first-page":"348","article-title":"Re-emergence of multi-drug resistant Shigella dysenteriae with added resistance to ciprofloxacin in north India & their plasmid profiles","volume":"122","author":"N Taneja","year":"2005","journal-title":"Indian J Med Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1099\/jmm.0.46095-0","article-title":"Identification and characterization of Shigella boydii 20 serovar nov., a new and emerging Shigella serotype","volume":"54","author":"DL Woodward","year":"2005","journal-title":"J Med Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jac\/dks061","article-title":"Cephalosporin-resistant Shigella flexneri over 9 years (2001\u201309) in India","volume":"67","author":"N Taneja","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/JCM.02247-06","article-title":"Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India","volume":"45","author":"N Taneja","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3201\/eid1408.080147","article-title":"Macrolide-resistant Shigella sonnei","volume":"14","author":"L Boumghar-Bourtchai","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/AAC.50.1.49-54.2006","article-title":"High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002","volume":"50","author":"S Sivapalasingam","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1128\/AAC.01463-10","article-title":"Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009","volume":"55","author":"JP Folster","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/AAC.02360-12","article-title":"Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States","volume":"57","author":"M Sjolund Karlsson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"MM Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella isolates from the global enteric multicenter study inform vaccine development","volume":"59","author":"S Livio","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CMR.00032-07","article-title":"Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion","volume":"21","author":"GN Schroeder","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CDLI.3.4.451-455.1996","article-title":"Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination","volume":"3","author":"D Cohen","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/IAI.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp","volume":"53","author":"EV Oaks","year":"1986","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0011-2240(73)90024-2","article-title":"Freeze-drying of live oral streptomycin dependent mutant Shigella vaccines: survival of streptomycin-dependent Shigella sonnei after freeze-drying","volume":"10","author":"V Damjanovic","year":"1973","journal-title":"Cryobiology"},{"key":"ref27","first-page":"285","article-title":"Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials","volume":"43","author":"W Bingrui","year":"1984","journal-title":"Arch Roum Pathol Exp Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1128\/IAI.64.11.4542-4548.1996","article-title":"Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG","volume":"64","author":"KL Kotloff","year":"1996","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/314759","article-title":"Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children","volume":"179","author":"S Ashkenazi","year":"1999","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/erv.09.127","article-title":"Inactivated and subunit vaccines to prevent shigellosis","volume":"8","author":"RW Kaminski","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/14760584.5.5.669","article-title":"Live-attenuated Shigella vaccines","volume":"5","author":"MM Venkatesan","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.vaccine.2005.11.040","article-title":"Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine","volume":"24","author":"EV Oaks","year":"2006","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2011.07.033","article-title":"Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine","volume":"29","author":"MS Riddle","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1016\/j.vaccine.2010.06.086","article-title":"Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers","volume":"28","author":"D Tribble","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/QCO.0b013e3282f88b92","article-title":"Shigellosis: the current status of vaccine development","volume":"21","author":"MN Kweon","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1128\/IAI.69.9.5230-5234.2001","article-title":"Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity","volume":"69","author":"V Rasolofo-Razanamparany","year":"2001","journal-title":"Infect Immun"},{"key":"ref37","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"KL Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1016\/j.vaccine.2016.08.034","article-title":"Development of recombinant vaccine candidate molecule against Shigella infection","volume":"34","author":"ST Chitradevi","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tibtech.2004.12.008","article-title":"The impact of genomics on vaccine design","volume":"23","author":"M Scarselli","year":"2005","journal-title":"Trends Biotechnol"},{"key":"ref40","first-page":"216","article-title":"Proteomics approaches towards antigen discovery and vaccine development","volume":"4","author":"CS Klade","year":"2002","journal-title":"Curr Opin Mol Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"M Pizza","year":"2000","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1093\/nar\/gkg874","article-title":"The complete genome sequence and analysis of Corynebacterium diphtheriae NCTC13129","volume":"31","author":"AM Cerdeno-Tarraga","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/0-387-25342-4_15","article-title":"Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis","volume":"568","author":"DF Kelly","year":"2005","journal-title":"Adv Exp Med Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1371\/journal.pcbi.0020071","article-title":"Immunoinformatics comes of age","volume":"2","author":"B Korber","year":"2006","journal-title":"PLoS Comput Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"RE Soria-Guerra","journal-title":"J Biomed Inform"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1743-422X-9-66","article-title":"Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site","volume":"9","author":"C Cubillos","year":"2012","journal-title":"Virol J"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00262-012-1259-8","article-title":"TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers","volume":"61","author":"K Barrios","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00002371-200209000-00008","article-title":"Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer","volume":"25","author":"R Gohara","year":"2002","journal-title":"J Immunother"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1158\/1078-0432.CCR-05-0235","article-title":"Phase I clinical trial of a HER-2\/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients","volume":"11","author":"MT Hueman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.cji.0000211333.06762.47","article-title":"Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients","volume":"30","author":"A Bins","year":"2007","journal-title":"J Immunother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3171\/JNS\/2008\/108\/5\/0963","article-title":"Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme","volume":"108","author":"S Izumoto","year":"2008","journal-title":"J Neurosurg"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1349-7006.2009.01416.x","article-title":"Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer","volume":"101","author":"M Miyazawa","year":"2010","journal-title":"Cancer Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/etm.2010.177","article-title":"Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer","volume":"2","author":"A Yamada","year":"2011","journal-title":"Exp Ther Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1757-4749-2-4","article-title":"Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata","volume":"2","author":"GB Nair","year":"2010","journal-title":"India. Gut Pathog"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a116134","article-title":"Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile","volume":"134","author":"C Ferreccio","year":"1991","journal-title":"Am J Epidemiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0264-410X(90)90094-3","article-title":"Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease","volume":"8","author":"DA Herrington","year":"1990","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0264-410X(95)00102-7","article-title":"A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity","volume":"13","author":"KL Kotloff","year":"1995","journal-title":"Vaccine"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"NY Yu","year":"2010","journal-title":"Bioinformatics"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1110\/ps.03479604","article-title":"Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions","volume":"13","author":"CS Yu","year":"2004","journal-title":"Protein Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/bioinformatics\/17.8.721","article-title":"Support vector machine approach for protein subcellular localization prediction","volume":"17","author":"S Hua","year":"2001","journal-title":"Bioinformatics"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/bioinformatics\/bti309","article-title":"PSLpred: prediction of subcellular localization of bacterial proteins","volume":"21","author":"M Bhasin","year":"2005","journal-title":"Bioinformatics"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"JE Larsen","year":"2006","journal-title":"Immunome Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"S Saha","year":"2006","journal-title":"Proteins"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12038-007-0004-5","article-title":"A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes","volume":"32","author":"M Bhasin","year":"2007","journal-title":"J Biosci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"R Vita","journal-title":"Nucleic Acids Res"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","article-title":"ProPred: prediction of HLA-DR binding sites","volume":"17","author":"H Singh","year":"2001","journal-title":"Bioinformatics"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1999.00743.x","article-title":"B-cell responses to a peptide epitope: mutations in heavy chain alone lead to maturation of antibody responses","volume":"97","author":"R Tuteja","year":"1999","journal-title":"Immunology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e34077","DOI":"10.1371\/journal.pone.0034077","article-title":"Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis","volume":"7","author":"G Dakshinamoorthy","year":"2012","journal-title":"PLoS One"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3748\/wjg.v9.i12.2711","article-title":"Expression of Helicobacter pylori Hsp60 protein and its immunogenicity","volume":"9","author":"Y Bai","year":"2003","journal-title":"World J Gastroenterol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1073\/pnas.92.11.4927","article-title":"Disulfide oxidoreductase activity of Shigella flexneri is required for release of Ipa proteins and invasion of epithelial cells","volume":"92","author":"M Watarai","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1128\/IAI.68.11.6449-6456.2000","article-title":"Key role for DsbA in cell-to-cell spread of Shigella flexneri, permitting secretion of Ipa proteins into interepithelial protrusions","volume":"68","author":"J Yu","year":"2000","journal-title":"Infect Immun"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"e22663","DOI":"10.1371\/journal.pone.0022663","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model","volume":"6","author":"D Pore","year":"2011","journal-title":"PLoS One"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1747-0285.2010.01021.x","article-title":"Synthetic peptide vaccine development: designing dual epitopes into a single pilin peptide immunogen generates antibody cross-reactivity between two strains of Pseudomonas aeruginosa","volume":"76","author":"C Hackbarth","year":"2010","journal-title":"Chem Biol Drug Des"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0168-1702(96)01311-1","article-title":"Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus","volume":"42","author":"OE Obeid","year":"1996","journal-title":"Virus Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0264-410X(90)90053-O","article-title":"Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination","volume":"8","author":"Y Hirabayashi","year":"1990","journal-title":"Vaccine"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(02)00341-2","article-title":"Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo","volume":"17","author":"A Phalipon","year":"2002","journal-title":"Immunity"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/JCM.27.1.162-167.1989","article-title":"Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections","volume":"27","author":"D Cohen","year":"1989","journal-title":"J Clin Microbiol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.icb7100025","article-title":"Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?","volume":"85","author":"A Phalipon","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/IAI.59.7.2341-2350.1991","article-title":"Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides","volume":"59","author":"RA Oberhelman","year":"1991","journal-title":"Infect Immun"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JCM.29.2.386-389.1991","article-title":"Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis","volume":"29","author":"D Cohen","year":"1991","journal-title":"J Clin Microbiol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/IAI.63.5.2054-2061.1995","article-title":"Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis","volume":"63","author":"D Islam","year":"1995","journal-title":"Infect Immun"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JVI.79.1.159-175.2005","article-title":"Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge","volume":"79","author":"CS Morello","year":"2005","journal-title":"J Virol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut","volume":"25","author":"SW Lin","year":"2007","journal-title":"Vaccine"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"IM Belyakov","year":"2009","journal-title":"J Immunol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3727\/096504014X13887748696789","article-title":"Cancer\/testis antigen HCA587-derived long peptide vaccine generates potent immunologic responses and antitumor effects in mouse model","volume":"21","author":"L Zhang","year":"2013","journal-title":"Oncol Res"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"e17712","DOI":"10.1371\/journal.pone.0017712","article-title":"Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses","volume":"6","author":"C Chen","year":"2011","journal-title":"PLoS One"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3892\/ijmm.2016.2512","article-title":"Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1\/Th2\/Th17-type cytokine responses in mice","volume":"37","author":"S Elhaik Goldman","year":"2016","journal-title":"Int J Mol Med"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/21645515.2015.1037057","article-title":"Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine","volume":"11","author":"X Teng","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.63.8.2941-2949.1995","article-title":"Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease","volume":"63","author":"D Islam","year":"1995","journal-title":"Infect Immun"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/IAI.63.1.289-296.1995","article-title":"Persistence of local cytokine production in shigellosis in acute and convalescent stages","volume":"63","author":"R Raqib","year":"1995","journal-title":"Infect Immun"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gut.34.2.194","article-title":"Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection","volume":"34","author":"DG de Silva","year":"1993","journal-title":"Gut"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1128\/IAI.72.11.6666-6675.2004","article-title":"Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections","volume":"72","author":"RE Brennan","year":"2004","journal-title":"Infect Immun"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"e93907","DOI":"10.1371\/journal.pone.0093907","article-title":"MP3: a software tool for the prediction of pathogenic proteins in genomic and metagenomic data","volume":"9","author":"A Gupta","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T03:21:59Z","timestamp":1602645719000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180505"}},"subtitle":[],"editor":[{"given":"Niyaz","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":93,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180505","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}